Mersana Therapeutics, Inc. financial data

Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
Location
840 Memorial Drive, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 295 % -18.2%
Debt-to-equity 940 % +209%
Return On Equity -401 % -51.9%
Return On Assets -38.6 % +41%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +2.45%
Common Stock, Shares, Outstanding 123M shares +1.92%
Entity Public Float 364M USD -9.79%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 123M shares +1.83%
Weighted Average Number of Shares Outstanding, Diluted 123M shares +1.83%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 34.8M USD -14.7%
Research and Development Expense 72.2M USD -58.1%
General and Administrative Expense 42.1M USD -34.5%
Nonoperating Income (Expense) 5.75M USD -18.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.1M USD +73.4%
Income Tax Expense (Benefit) 418K USD
Net Income (Loss) Attributable to Parent -74.6M USD +62.1%
Earnings Per Share, Basic -0.59 USD/shares +66.7%
Earnings Per Share, Diluted -0.59 USD/shares +66.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 78.9M USD -57.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Assets, Current 161M USD -35.7%
Property, Plant and Equipment, Net 3.83M USD -3.86%
Operating Lease, Right-of-Use Asset 5.39M USD -36%
Other Assets, Noncurrent 978K USD +105%
Assets 170M USD -35.5%
Accounts Payable, Current 2.03M USD -84.3%
Employee-related Liabilities, Current 10.2M USD +42.4%
Accrued Liabilities, Current 18.6M USD -36.5%
Contract with Customer, Liability, Current 31.4M USD +45.3%
Liabilities, Current 68.3M USD +0.54%
Contract with Customer, Liability, Noncurrent 83.9M USD -24.8%
Operating Lease, Liability, Noncurrent 2.3M USD -62.1%
Other Liabilities, Noncurrent 21K USD -68.7%
Liabilities 168M USD -20%
Accumulated Other Comprehensive Income (Loss), Net of Tax 25K USD +2400%
Retained Earnings (Accumulated Deficit) -881M USD -9.25%
Stockholders' Equity Attributable to Parent 1.05M USD -98%
Liabilities and Equity 170M USD -35.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.7M USD -12.6%
Net Cash Provided by (Used in) Financing Activities 5.83M USD -73%
Net Cash Provided by (Used in) Investing Activities -72.5M USD -5297%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 123M shares +1.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -99.4M USD -1540%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 79.3M USD -57.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 871K USD +10.1%
Deferred Tax Assets, Valuation Allowance 239M USD +25.6%
Deferred Tax Assets, Gross 242M USD +24.9%
Operating Lease, Liability 8.4M USD -26.1%
Payments to Acquire Property, Plant, and Equipment 132K USD -85.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -74.6M USD +62.1%
Lessee, Operating Lease, Liability, to be Paid 9.47M USD -29.8%
Operating Lease, Liability, Current 3.75M USD +19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.19M USD +0.99%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.98M USD +3.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.07M USD -49.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.31M USD -68.7%
Deferred Tax Assets, Operating Loss Carryforwards 127M USD +11.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.31M USD -68.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 423K USD +32.6%
Deferred Tax Assets, Net of Valuation Allowance 2.08M USD -27%
Share-based Payment Arrangement, Expense 17.2M USD -23.1%
Interest Expense 4.09M USD +14.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%